Invention Application
- Patent Title: Arylamine mch r1 antagonists
- Patent Title (中): 芳胺mch r1拮抗剂
-
Application No.: US10576765Application Date: 2004-10-21
-
Publication No.: US20070078125A1Publication Date: 2007-04-05
- Inventor: Kevin Barvian , Anthony Handlon , Donald Hertzog , Clifton Hyman
- Applicant: Kevin Barvian , Anthony Handlon , Donald Hertzog , Clifton Hyman
- Assignee: GLAXO GROUP LIMITED
- Current Assignee: GLAXO GROUP LIMITED
- Priority: US60513800 20031023
- International Application: PCT/US04/34846 WO 20041021
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/55 ; C07D498/02
Abstract:
This invention relates to novel arylamines which are antagonists of the melanin-concentrating hormone receptor 1 (MCH R1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines for the treatment of obesity, diabetes, depression, and/or anxiety. Compounds of the invention have the formula:
Information query
IPC分类:
